TIS tissue therapies limited

Hey guys, long time creeper first time...

  1. 11 Posts.
    Hey guys, long time creeper first time poster.

    http://www.biotec.no/en/news/237-woulganrbiogel-available-for-professional-wound-and-ulcer-treatment-in-2013.html

    I came across this link today, it was posted on a biomed news site a few days ago. Although the product itself differentiates from vitrogrow it does claim to be effective at healing diabetic ulcers. Does anyone think this could be a possible threat to vitrogrow?


    "Woulgan® Biogel will be available in tubes containing 4 grams each, for use on individual patients. The biogel is to be applied onto dry or slightly running skin wounds, such as for instance diabetic ulcers, leg ulcers, graft and donor sites, post-operative surgical wounds, trauma wounds, 1st and 2nd degree burns, and abrasions and lacerations."

    "The company has applied for approval of the product as a medical device containing SBG as the medicinal component. This product category falls within Class III, Rule 13 of the EU regulation on medical devices."
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.